SHILPA MEDICARE LTD. - 530549 - RELATED PARTY TRANSACTIONS U/R 23(9)
Submission of Related Party Transactions U/R 23(9) of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 for the Half Year Ended 31st March, 2021.24-06-2021
24-06-2021
SHILPA MEDICARE LTD. - 530549 - Intimation U/R 30 Of The SEBI(LODR) Regulations
Shilpa Medicare Limited Launches, first time in the world fast dissolving Oral Thin Films of Paracetamol, Molshil(r) Oral Thin Films in India22-06-2021
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
We hereby submit the disclosure under Regulation 37(6) of SEBI (LODR) Regulations, 2015, in relation to the proposed amalgamation of M/s INM Technologies Private Limited (a wholly owned subsidiary of Shilpa Medicare Limited) with Shilpa Medicare Limited We request you to kindly consider and take the same on record.19-06-2021
Shilpa Medicare Ltd - 530549 - RELATED PARTY TRANSACTIONS U/R 29(3)
Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith enclosed Related Party Transactions on consolidated basis in the format as per the relevant Accounting Standards for the Year ended 31st March, 202105-06-2021
Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tano Mauritius India FVCI II05-06-2021
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Meeting Updates
APPOINTMENT OF MR. ALPESH DALAL AS CHIEF FINANCIAL OFFICE OF THE COMPANY01-06-2021
SHILPA MEDICARE LTD. - 530549 - Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Unmodified Opinion.
I Alpesh Dalal, Chief Financial Officer of Shilpa Medicare Limited (CIN:L85110KAI987PLC008739) having registered office at 12-6-2141 A-I, Shilpa House, Hyderabad Road, Raichur - 584135, Karnataka, hereby declare that the Statutory Auditors of the Company M/s Brahmayya & Co. Chartered Accountants represented by its Partner Mr. K. Shravan holding membership Number: 215798 have issued an audit report with unmodified opinion on audited financial results for the Quarter and Year Ended 31 st March, 2021. The declaration is issued in compliance of Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015 as amended vide its circular no CIR/CFDICMDI56/2016 dated 27th May, 2016. This is for your information and Records.01-06-2021
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find herewith enclosed copy of 04th Quarter and Financial Year 2020-21 Results presentation made to analysts and Investors.31-05-2021
Shilpa Medicare Ltd - 530549 - Corporate Action-Board approves Dividend
With reference to the captioned subject please be noted that the board of directors at their meeting held today 31.05.2021, to inter alia considered and approved the following. 1. Audited Standalone and Consolidated Financial Statements for the Financial Year ended 31st March, 2021. 2. Auditor's Report for the Financial Year ended 31st March, 2021. 3. To recommend the Dividend @ 110% (i.e. Rs.1.10 per every equity share of face value of Rs.1) for the Financial Year 2020-21 subject to the approval of shareholders at the ensuing Annual General Meeting. 4. Appointment of Mr. Alpesh Dalal as Chief Financial Officer of the Company. Brief profile is enclosed as an annexure The board Meeting Started at 11:30 am and Concluded at 15:10 PM.31-05-2021
Shilpa Medicare Ltd - 530549 - RESULTS FOR THE FY 2020-21
With reference to the captioned subject please be noted that the board of directors at their meeting held today 31.05.2021, to inter alia considered and approved the following. 1. Audited Standalone and Consolidated Financial Statements for the Financial Year ended 31st March, 2021. 2. Auditor's Report for the Financial Year ended 31st March, 2021. 3. To recommend the Dividend @ 110% (i.e. Rs.1.10 per every equity share of face value of Rs.1) for the Financial Year 2020-21 subject to the approval of shareholders at the ensuing Annual General Meeting. 4. Appointment of Mr. Alpesh Dalal as Chief Financial Officer of the Company. Brief profile is enclosed as an annexure The board Meeting Started at 11:30 am and Concluded at 3:10 PM.31-05-2021